Norman G. Hoffmann, Ph.D.
Norman G. Hoffmann, Ph.D., founder of Evince Diagnostics, is a nationally and internationally recognized expert in the development of practical, scientifically sound assessment instruments and the evaluation of behavioral health treatment programs. His assessment instruments are used throughout the United States, Canada, and parts of Europe. The instruments include brief and comprehensive interviews for the identification of mental health and substance use disorders in accordance with current diagnostic criteria as well as treatment planning aids based on the ASAM Criteria.
He has provided consultation services on assessment and evaluation issues for state and federal agencies, corporations and public organizations in the US, Canada, Sweden, and Norway. A popular current area consists of assisting treatment programs in the implementation of empirically driven assessment and information systems to facilitate decision support, outcome documentation, and continuous quality improvement protocols.
Dr. Hoffmann led the team that developed the first placement criteria for multiple levels of care and was the lead author on the first American Society of Addiction Medicine patient placement criteria. His work on treatment evaluation provided evidence for the societal and financial benefits from addictions treatment and a foundation for empirically supported funding of treatment services. Dr. Hoffmann served on first joint accreditation panel for prisons, probation, and parole in the United Kingdom. His publications include more than 200 articles, book chapters, and other publications.
Dr. Hoffmann received his doctorate in clinical psychology from the University of Minnesota. Although employed largely in the private sector, his faculty appointments include the University of Texas Medical Branch, University of Minnesota, and Brown University. He is currently adjunct professor of psychology at Western Carolina University
For upcoming presentations and workshops, to schedule a workshop or presentation, or to get more information concerning consultations, please contact Dr. Hoffmann via evinceassessment@aol.com or by calling 828-454-9960.
- Career Highlights
- C.V.
Quantity
Unit Cost
1-10
$7.75
11-50
$7.50
51+
$6.90
The CAAPE-5 is a comprehensive interview that documents substance specific and common mental health conditions based on the DSM-5. It also informs three dimensions of the ASAM Criteria. Download a sample report below.
Benefits
- Consistent and efficient identification of problems among adults
- DSM-5 compatible diagnostic documentation
- Empirically validated relapse risks indicators
- Instant report of findings
- Inform ASAM Criteria Dimensions 1,3, & 5
Conditions Covered
- All substance use disorders
- Major depressive episode
- Manic episode
- Bipolar indications
- Panic disorder
- PTSD
- Indications of anxiety and obsessive compulsive issues
- Antisocial personality disorder
- Screens for other personality disorders: borderline, paranoid, schizoid, and dependent
Application
Initial clinical intake: The CAAPE‐5 is an ideal tool for performing a mental health and substance use disorder assessment as part of any routine clinical intake when both addictions and mental health disorders need to be considered.
Drug court evaluations: The CAAPE-5 covers conditions that should be considered by the court in adjudicating individuals in drug court proceedings.
Documentation of severity: The DSM‐5 defines severity for substance use disorders in terms of the number of positive diagnostic criteria. Research has also documented that five of the eleven criteria are more strongly associated with a severe diagnosis.
Verification of improvement: Reviewing disorders with positive diagnostic findings can determine if the conditions have improved or if remission can be documented.
Informing Dimensions 1, 3, and 5 of the ASAM Criteria:
- Dimension 1: The CAAPE‐5 questions on recent use patterns can identify possible withdrawal concerns.
- Dimension 3: The extensive coverage of mental health conditions provides substantial information on commonly occurring co‐occurring conditions.
- Dimension 5: Both demographic and clinical content covered by the CAAPE‐5 are related to relapse risks after addictions treatment.
Motivational enhancement: Reviewing CAAPE‐5 results with clients can aid in motivational enhancement. Individuals who are presented with the detailed behaviors and symptoms of their conditions may be more likely to accept referral and become engaged in their treatment plans.
Other common applications: Evaluation of adults in child protection cases and identification of problem prevalence among inmates in local jails.
Administration
- Time requirement from 30 to 45 minutes depending on the number of positive responses
- Two online administration options:
- Computer prompted - clinician/technician reads questions and enters response
- Computer administered - clinician/technician sets up interview and patient interacts directly with the program
- Paper option: purchase interview in booklet form from www.changecompanies.net.
- Training on the use of the paper version available from Evince Diagnostics
- Purchased in packets of 25 interviews with summary form for scoring